BUZZ - Shares of Australia's Tuas hit a two-month high as Citi raises its profit forecast
路透社2026/09/21 06:01September 21 - ** Shares of Australian Tuas Ltd (TUA.AX) rose as much as 4% to 2.35 AUD, reaching their highest level since July 20
** The stock is on track for a sixth consecutive day of gains
** Citi has raised its EBITDA forecast for fiscal years 2026 to 2028 by 5% to 17% to reflect stronger-than-expected growth momentum in the first half
** However, the broker remains cautious on the company’s latest developments, stating that the Infocomm Media Development Authority (IMDA) of Singapore’s investigation into spectrum misuse will impact operating expenses (opex), and compliance costs are expected to rise
** In May, Singapore’s Infocomm Media Development Authority (IMDA) stated that its mobile network subsidiary Simba may have used unallocated radio frequency bands (link) to provide mobile services
** Citi expects operating expenses may rise in the second half and the EBITDA margin to decline in the second half of 2026
** Taking into account regulatory impacts on licensing and costs, Citi has lowered its target price from 9.95 AUD to 3.35 AUD while maintaining its “buy” rating
** Year-to-date, the stock price has fallen nearly 67%
(For the convenience of non-English speakers, Reuters provides automated translations of its reports in several other languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the translated text. Automated translations are provided solely for the convenience of readers. Reuters is not liable for any damage or loss arising from the use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).